0xa037190057dc4dff19c0acee4562ee10269d9195
KalshiScience and TechnologyNo fixed close dateBefore Jan 1, 2032
If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2032, then the market resolves to Yes.
One plain read on where this price sits, from the rules, the book and the news.
453 contracts resting, best Yes bid 3¢, best No bid 43¢

PredictionSwap is a prediction market aggregator and ai analysis tool.
We help you predict the future using AI with advanced algorithms and up to date information.